Abraham Scaria

3.1k total citations
54 papers, 2.4k citations indexed

About

Abraham Scaria is a scholar working on Molecular Biology, Genetics and Ophthalmology. According to data from OpenAlex, Abraham Scaria has authored 54 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 26 papers in Genetics and 15 papers in Ophthalmology. Recurrent topics in Abraham Scaria's work include Virus-based gene therapy research (25 papers), Retinal Development and Disorders (16 papers) and Retinal Diseases and Treatments (13 papers). Abraham Scaria is often cited by papers focused on Virus-based gene therapy research (25 papers), Retinal Development and Disorders (16 papers) and Retinal Diseases and Treatments (13 papers). Abraham Scaria collaborates with scholars based in United States, China and France. Abraham Scaria's co-authors include William S.M. Wold, Ann E. Tollefson, Seng H. Cheng, Terry Hermiston, Michael Lukason, Samuel C. Wadsworth, J.S. Ryerse, Elizabeth Barry, Guo-Xiang Ruan and Dan Yu and has published in prestigious journals such as The Lancet, Blood and PLoS ONE.

In The Last Decade

Abraham Scaria

54 papers receiving 2.3k citations

Peers

Countries citing papers authored by Abraham Scaria

Since Specialization

Citations

This map shows the geographic impact of Abraham Scaria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Scaria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Scaria more than expected).

Fields of papers citing papers by Abraham Scaria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abraham Scaria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Scaria. The network helps show where Abraham Scaria may publish in the future.

Co-authorship network of co-authors of Abraham Scaria

This figure shows the co-authorship network connecting the top 25 collaborators of Abraham Scaria. A scholar is included among the top collaborators of Abraham Scaria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abraham Scaria. Abraham Scaria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AAV Gene Augmentation of Truncated Complement Factor H Differentially Rescues Ocular Complement Dysregulation in a Mouse Model 2023 ·Investigative Ophthalmology & Visual Science ·(unknown), Mikael Klingeborn, Una Kelly, Lindsey A. Chew, Aravind Asokan, Garth Devlin, Sharon Smith, Lisa R. Keyes, Adrian M. Timmers, Abraham Scaria, Catherine Bowes Rickman	5
2	Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain 2018 ·Gene Therapy ·Jennifer A. Sullivan, Lisa M. Stanek, Michael Lukason, Jie Bu, (unknown), Elizabeth Barry, Catherine R. O’Riordan, Lamya S. Shihabuddin, Seng H. Cheng, Abraham Scaria	27
3	3-Year Interim Safety Profile of Adeno-Associated Virus Serotype 2-soluble Variant of the Vascular Endothelial Growth Factor Receptor Type 1 (AAV2-sFLT01) Administered by Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration 2017 ·Investigative Ophthalmology & Visual Science ·(unknown), (unknown), Peter A. Campochiaro, Jeffrey S. Heier, Pravin U. Dugel, (unknown), Annie Purvis, (unknown), (unknown), (unknown), Abraham Scaria, Ronald Buggage	2
4	CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10 2017 ·Molecular Therapy ·Guo-Xiang Ruan, Elizabeth Barry, Dan Yu, Michael Lukason, Seng H. Cheng, Abraham Scaria	212
5	Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes 2017 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), (unknown), Brenda Burnham, (unknown), (unknown), (unknown), Abraham Scaria, Seng H. Cheng, Catherine R. O’Riordan	115
6	Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1 2015 ·Gene Therapy ·Feng Shen, Li Mao, Weihong Zhu, Michael T. Lawton, Peter Pecháň, P. Colosi, Zhijian Wu, Abraham Scaria, Hua Su	5
7	Translational Fidelity of Intrathecal Delivery of Self-Complementary AAV9–Survival Motor Neuron 1 for Spinal Muscular Atrophy 2014 ·Human Gene Therapy ·Marco A. Passini, Jie Bu, Amy M. Richards, Christopher M. Treleaven, Jennifer A. Sullivan, Catherine R. O’Riordan, Abraham Scaria, Adrian P. Kells, Lluı́s Samaranch, Waldy San Sebastián, Thais Federici, Massimo S. Fiandaca, Nicholas M. Boulis, Krystof S. Bankiewicz, Lamya S. Shihabuddin, Seng H. Cheng	72
8	Aurintricarboxylic acid increases yield of HSV-1 vectors 2014 ·Molecular Therapy — Methods & Clinical Development ·Peter Pecháň, (unknown), (unknown), Hillard Rubin, Samuel C. Wadsworth, Abraham Scaria	4
9	Interleukin-17 neutralization ameliorates retinal degeneration in Cx3cr1-/-/Ccl2-/-/Crb1rd8 mice 2013 ·Investigative Ophthalmology & Visual Science ·Daniel Ardeljan, Yujuan Wang, De Fen Shen, Mones Abu‐Asab, Jingsheng Tuo, Cheng‐Rong Yu, Gary L. White, Sam Wadsworth, Abraham Scaria, Chi‐Chao Chan	2
10	Local gene delivery of heme oxygenase-1 by adeno-associated virus into osteoarthritic mouse joints exhibiting synovial oxidative stress 2012 ·Osteoarthritis and Cartilage ·(unknown), Dinesh S. Bangari, Patty J. Ewing, (unknown), Patricia Berthelette, Cathleen Sookdeo, Elizabeth Hutto, (unknown), Jennifer A. Sullivan, G. Matthews, Abraham Scaria, (unknown)	16
11	sFLT01: A Novel Fusion Protein with Antiangiogenic Activity 2011 ·Molecular Cancer Therapeutics ·Rebecca G. Bagley, Leslie Kurtzberg, William Weber, Tri‐Hung Nguyen, Stéphanie Roth, (unknown), Min Yao, Brenda Richards, Mindy Zhang, Peter Pecháň, (unknown), Abraham Scaria, Johanne Kaplan, Beverly A. Teicher	20
12	AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2−/−/Cx3cr1−/− mice 2011 ·Neurobiology of Aging ·Jingsheng Tuo, Jijing Pang, Xiaoguang Cao, Defen Shen, Jun Zhang, Abraham Scaria, Samuel C. Wadsworth, Peter Pecháň, Sanford L. Boye, William W. Hauswirth, Chi‐Chao Chan	19
13	Inhibition of Choroidal Neovascularization in a Nonhuman Primate Model by Intravitreal Administration of an AAV2 Vector Expressing a Novel Anti-VEGF Molecule 2010 ·Molecular Therapy ·Michael Lukason, (unknown), Hillard Rubin, Peter Pecháň, Qiuhong Li, Ivana K. Kim, Szilárd Kiss, (unknown), Margaret E. Collins, Joan W. Miller, William W. Hauswirth, Timothy K. MacLachlan, Samuel C. Wadsworth, Abraham Scaria	67
14	Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization 2008 ·Gene Therapy ·Peter Pecháň, Hillard Rubin, Michael Lukason, (unknown), (unknown), William W. Hauswirth, Sam Wadsworth, Abraham Scaria	83
15	Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection 2004 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Anna M. van Heeckeren, Abraham Scaria, Mark Schluchter, Thomas W. Ferkol, Samuel C. Wadsworth, Pamela B. Davis	26
16	Adenoviral Vectors Stimulate Murine Natural Killer Cell Responses and Demonstrate Antitumor Activities in the Absence of Transgene Expression 2002 ·Molecular Therapy ·Melanie C. Ruzek, Brian F. Kavanagh, Abraham Scaria, Susan Richards, Richard D. Garman	32
17	Adenoviral Vector Expressing ICP47 Inhibits Adenovirus-Specific Cytotoxic T Lymphocytes in Nonhuman Primates 2000 ·Molecular Therapy ·Abraham Scaria, Jennifer A. Sullivan, Judith A. St. George, Johanne Kaplan, Michael Lukason, James E. Morris, (unknown), (unknown), Richard J. Gregory, Samuel C. Wadsworth	10
18	Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway 1997 ·Gene Therapy ·Abraham Scaria, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	61
19	Fine-Mapping of Sequences That Suppress Splicing in the E3 Complex Transcription Unit of Adenovirus 1994 ·Virology ·Abraham Scaria, William S.M. Wold	12
20	Preirradiation of host cells does not alter blockage of simian virus 40 replication forks by pyrimidine dimers 1988 ·Mutation Research/DNA Repair Reports ·Abraham Scaria, Howard J. Edenberg	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact